Author: Victoria L Henson / Editor: Jason M Kendall / Reviewer: Louise Burrows, Peter Kilgour / Code: / Published: 22/03/2021
After completing this session you will be able to:
- Define cardiogenic pulmonary oedema
- Describe the pathophysiology of cardiogenic pulmonary oedema
- Clinically assess a breathless patient and recognise cardiogenic pulmonary oedema
- Investigate and treat cardiogenic pulmonary oedema within the emergency department
- Describe the long-term outcome for this patient group
References
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal (2016) 37, 21292200.
- O’Driscoll BR, Howard LS, Earis J on behalf of the BTS Emergency Oxygen Guideline Development Group, et al British Thoracic Society Guideline for oxygen use in adults in healthcare and emergency settings BMJ Open Respiratory Research 2017;4:e000170. doi: 10.1136/bmjresp-2016-000170.
- F M R Vital, H Saconato, M T Ladeira, A Sen, et al. Noninvasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary edema (Review). Cochrane Database of Systemic Reviews 2008, Issue 3.Art.No.: CD005351.DOI: 10.1002/14651858.CD005351.pub2.
- A Gray, S Goodacre, D E Newby, M Masson et al. Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema. The New England Journal of Medicine. July 10 2008. Vol 359, iss 2: pg 142.
- A Mattu, J P Martinez, D S Kelly. Modern Management of Cardiogenic Pulmonary Edema. Emergency Medicine Clinics of North America 23(2005) 1105-1125.
- D Feldman, D M Menachemi, W T Abraham, R K Wexler. Management strategies for stage D patients with acute heart failure. Clinical Cardiology 31, 7, 297-301 (2008).
- G Cotter, E Metzkor, Z Faigenerg, R Miller, A Simovitz et al. Randomised trial of high dose isosorbide dinitrate plus low dose furosemide versus high dose furosemide plus low dose isosorbide dinitrate in severe pulmonary oedema. The Lancet. Vol 351, February 7th 1998 page389-393.
- M Metra, J R Teerlink, A A Voors, G M Felker, O Milo-Cotter et al. Vasodilators in the treatment of acute heart failure: what we know, what we dont. Heart failure Reviews. DOI 10.1007/s10741-008-9127-5.
